Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Vas Narasimhan
Vas Narasimhan
Novartis CEO plans gene therapy price 'far lower' than $4 million to $5 million range
Yahoo/Reuters
Thu, 05/23/19 - 09:48 am
Novartis
Pharma CEOs
Vas Narasimhan
gene therapy
SMA
drug pricing
Zolgensma
Commentary: Novartis CEO: Gene therapy offers hope of cures in one treatment, but US needs new pricing and payment model
CNBC
Fri, 05/17/19 - 07:21 pm
gene therapy
cancer
Novartis
Pharma CEOs
Vas Narasimhan
It’s a seller’s world in biotech M&A, and Novartis CEO Vas Narasimhan has his check book out and pen ready
Endpoints
Tue, 04/9/19 - 08:31 am
Novartis
M&A
Alcon
Pharma CEOs
Vas Narasimhan
Novartis CEO's $50 Billion of Deals Was Just the First Act
Yahoo/Bloomberg
Thu, 04/4/19 - 12:01 pm
Novartis
M&A
Vas Narasimhan
Pharma CEOs
Pharma Novartis chief’s 2018 take-home pay suffers—not from Cohen but from low-grade returns
Fierce Pharma
Wed, 02/13/19 - 11:49 am
Pharma CEOs
Novartis
executive pay
Vas Narasimhan
Novartis CEO lauds Trump administration plan to overhaul rebates
Yahoo/Reuters
Thu, 02/7/19 - 09:40 am
Novartis
Vas Narasimhan
Pharma CEOs
drug pricing
Donald Trump
drug rebates
As Novartis Eyes Growth in 2019, the Company Will Likely Cut Some Prices
BioSpace
Wed, 01/30/19 - 07:05 pm
Novartis
drug pricing
Pharma CEOs
Vas Narasimhan
Novartis teams up with Oxford researchers to crunch big data into clinical insights
Endpoints
Fri, 01/18/19 - 12:05 am
Novartis
University of Oxford
Vas Narasimhan
machine learning
artificial intelligence
Novartis CEO Who Wanted To Bring Tech Into Pharma Now Explains Why It's So Hard
Forbes
Thu, 01/17/19 - 12:04 am
Novartis
Pharma CEOs
Vas Narasimhan
digital pharma
Novartis building out cell and gene therapy platform that'll lead the pack, CEO promises
Fierce Pharma
Tue, 01/8/19 - 12:38 am
Novartis
Pharma CEOs
CAR-T
Kymriah
Vas Narasimhan
JPMHC 2019
Novartis CEO calls for cultural shift to cater for millennial generation
Pharmafile
Sat, 12/8/18 - 12:22 pm
Novartis
Pharma CEOs
Vas Narasimhan
millennials
Novartis CEO Vas Narasimhan On The Price Of Gene Therapies: 'It's A Challenge We Have To Solve'
Forbes
Thu, 11/29/18 - 11:11 am
Novartis
Pharma CEOs
Vas Narasimhan
gene therapy
AveXis
Novartis CEO Is Going All in With Some Big Bets on R&D
BioSpace
Wed, 11/21/18 - 12:18 pm
Novartis
Pharma CEOs
Vas Narasimhan
R&D
Vas Narasimhan, Novartis CEO, explains reasons behind 2,100 jobs cut
GoinPharma
Sun, 09/30/18 - 03:49 pm
Novartis
layoffs
Vas Narasimhan
Pharma CEOs
Under the gun for Cohen deal, Novartis CEO Vas Narasimhan hits the brakes on US drug price hikes
Endpoints
Wed, 07/18/18 - 09:30 am
Novartis
Vas Narasimhan
drug pricing
Donald Trump
Michael Cohen
Novartis CEO Vas Narasimhan faces a heap of burning questions — but so far offers no public answers
Endpoints
Tue, 05/15/18 - 09:11 pm
Novartis
Pharma CEOs
Vas Narasimhan
Donald Trump
Novartis CEO Vas Narasimhan is raising the bar on second-gen cancer drug studies
Endpoints
Sat, 04/21/18 - 12:44 pm
Novartis
cancer
Pharma CEOs
Vas Narasimhan
Why Did Novartis Spend $9 Billion On Gene Therapy? CEO Says: 'A Journey To Focus On Data And Digital'
Forbes
Mon, 04/9/18 - 03:31 pm
Novartis
Vas Narasimhan
M&A
gene therapy
AveXis
Swiss Pharma Novartis Gets a Taste of Silicon Valley
Yahoo/Bloomberg
Thu, 03/15/18 - 11:12 am
Novartis
Silicon Valley
Vas Narasimhan
digital pharma
Pharma gets a seat at the table at private dinner with Trump at Davos
Stat
Sat, 01/27/18 - 09:44 am
Donald Trump
pharma industry
Vas Narasimhan
Novartis
Werner Baumann
Bayer
Pages
« first
‹ previous
1
2
3
next ›
last »